BioCentury | Apr 26, 2010
Company News

Entest, Medistem deal

...and $2 million in Entest shares. Thomas Ichim, CEO of Medistem, will become CSO of Entest...
...in 4Q10. Entest is a subsidiary of Bio-Matrix Scientific Group Inc. (OTCBB:BMSN, San Diego, Calif.) Entest BioMedical Inc....
BioCentury | Apr 12, 2010
Company News

Entest management update

Entest BioMedical Inc. (OTCBB:ENTB), San Diego, Calif. Business: Neurology, Endocrine Hired: Tammy Reynolds as CFO, formerly with Science Applications International Corp. WIR Staff...
BioCentury | Nov 2, 2009
Company News

Entest, Therinject deal

...earlier this year to develop an immunotherapeutic vaccine for cancer. Further terms were not disclosed. Entest...
...diabetes screening products and is developing adipose-derived stem cells to treat traumatic brain injury (TBI). Entest...
...a subsidiary of Bio-Matrix Scientific Group Inc. (OTCBB:BMSN, San Diego, Calif.) (see BioCentury, Aug. 17). Entest BioMedical Inc....
BioCentury | May 4, 2009
Company News

Bio-Matrix Scientific diagnostic news

...Bio-Matrix plans to spin out its subsidiary Entest Biomedical Inc. into a public company, which will focus on...
...by Entest, is conducting pilot testing of the newco's undisclosed lead diagnostic for gestational diabetes. Entest...
Items per page:
1 - 4 of 4
BioCentury | Apr 26, 2010
Company News

Entest, Medistem deal

...and $2 million in Entest shares. Thomas Ichim, CEO of Medistem, will become CSO of Entest...
...in 4Q10. Entest is a subsidiary of Bio-Matrix Scientific Group Inc. (OTCBB:BMSN, San Diego, Calif.) Entest BioMedical Inc....
BioCentury | Apr 12, 2010
Company News

Entest management update

Entest BioMedical Inc. (OTCBB:ENTB), San Diego, Calif. Business: Neurology, Endocrine Hired: Tammy Reynolds as CFO, formerly with Science Applications International Corp. WIR Staff...
BioCentury | Nov 2, 2009
Company News

Entest, Therinject deal

...earlier this year to develop an immunotherapeutic vaccine for cancer. Further terms were not disclosed. Entest...
...diabetes screening products and is developing adipose-derived stem cells to treat traumatic brain injury (TBI). Entest...
...a subsidiary of Bio-Matrix Scientific Group Inc. (OTCBB:BMSN, San Diego, Calif.) (see BioCentury, Aug. 17). Entest BioMedical Inc....
BioCentury | May 4, 2009
Company News

Bio-Matrix Scientific diagnostic news

...Bio-Matrix plans to spin out its subsidiary Entest Biomedical Inc. into a public company, which will focus on...
...by Entest, is conducting pilot testing of the newco's undisclosed lead diagnostic for gestational diabetes. Entest...
Items per page:
1 - 4 of 4